{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:17:29Z","timestamp":1781716649619,"version":"3.54.5"},"reference-count":54,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["075-15-2022-301"],"award-info":[{"award-number":["075-15-2022-301"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"abstract":"<jats:p>Mutations in the FLT3 gene not only lead to abnormalities in its structure and function, but also affect the expression of other genes involved in leukemogenesis. This study evaluated the expression of genes that are more characteristic of neuroblastoma but less studied in leukemia. N-MYC oncogene expression was found to be more than 3-fold higher in primary AML patients carrying the FLT3-ITD mutation compared to carriers of other mutations as well as patients with normal karyotype (p = 0.03946). In contrast to the expression of several genes (C-MYC, SPT16, AURKA, AURKB) directly correlated to the allelic load of FLT3-ITD, the expression of the N-MYC oncogene is extremely weakly related or independent of it (p = 0.0405). Monitoring of N-MYC expression in some patients with high FLT3-ITD allelic load receiving therapy showed that a decrease in FLT3-ITD allelic load is not always accompanied by a decrease in N-MYC expression. On the contrary, N-MYC expression may remain elevated during the first three months after therapy, which is additional evidence of the emergence of resistance to therapy and progression of AML.<\/jats:p>","DOI":"10.3390\/pathophysiology30030024","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:32:35Z","timestamp":1690882355000},"page":"296-313","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation"],"prefix":"10.3390","volume":"30","author":[{"given":"Konstantin","family":"Bogdanov","sequence":"first","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kudryavtseva","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Fomicheva","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Churkina","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-7961","authenticated-orcid":false,"given":"Elza","family":"Lomaia","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Girshova","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Osipov","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7682-440X","authenticated-orcid":false,"given":"Andrey","family":"Zaritskey","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.278.5340.1059","article-title":"Oncogenic transcription factors in the human acute leukemias","volume":"278","author":"Look","year":"1997","journal-title":"Science"},{"key":"ref_2","first-page":"32","article-title":"Molecular biology of acute myeloid leukemia","volume":"24","author":"Caligiuri","year":"1997","journal-title":"Semin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"key":"ref_4","first-page":"55","article-title":"Rearrangement of the ALL(MLL) in acute myeloid leukemia with normal cytogenetic","volume":"58","author":"Caligiuri","year":"1998","journal-title":"Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1182\/blood-2006-06-030312","article-title":"FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia","volume":"111","author":"Kim","year":"2008","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2017-01-760595","article-title":"Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia","volume":"130","author":"Dovey","year":"2017","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4326e35","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3 activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identifica-tion of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/gcc.22100","article-title":"NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR","volume":"52","author":"Akiki","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/5DGB59KQA527PD47","article-title":"Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations","volume":"122","author":"Oyarzo","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: Review of current knowledge and evidence","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/cas.14274","article-title":"FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development","volume":"111","author":"Kiyoi","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/10428190500261740","article-title":"Mutant FLT3 signalling contributes to a block in myeloid differentiation","volume":"46","author":"Zheng","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-016-0292-z","article-title":"Immunoprofiling of leukemic stem cells CD34+\/CD38\u2212\/CD123+ delineate FLT3\/ITD-positive clones","volume":"9","author":"Gillis","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.leu.2401130","article-title":"Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product","volume":"12","author":"Kiyoi","year":"1998","journal-title":"Leukemia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2007.06525.x","article-title":"FLT3\/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem\/progenitor cells","volume":"137","author":"Li","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.celrep.2014.10.039","article-title":"Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis","volume":"9","author":"Chatterjee","year":"2014","journal-title":"Cell Rep."},{"key":"ref_18","first-page":"656","article-title":"Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR","volume":"52","author":"Handschuh","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10677","DOI":"10.1158\/0008-5472.CAN-07-1118","article-title":"Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice","volume":"67","author":"Kawagoe","year":"2007","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"31615","DOI":"10.1038\/srep31615","article-title":"SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells","volume":"6","author":"Ikeda","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1084\/jem.20151323","article-title":"Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms","volume":"212","author":"Mullenders","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41375-021-01452-6","article-title":"A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1134\/S1068162017040033","article-title":"Identification of oncogene mutations in leukemia patients using microchip-based PCR analysis","volume":"43","author":"Bogdanov","year":"2017","journal-title":"Russ. J. Bioorganic Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014A Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014A Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.leu.2403835","article-title":"DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification","volume":"19","author":"Libura","year":"2005","journal-title":"Leukemia"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Shah, A., Sharma, A., Katiyar, S., Gupta, A., and Chaturvedi, C.P. (2022). Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123001"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1525-1578(10)60458-8","article-title":"Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay","volume":"5","author":"Murphy","year":"2003","journal-title":"J. Mol. Diagn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1182\/blood-2005-05-2164","article-title":"Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations","volume":"106","author":"Schlenk","year":"2005","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3892\/or.2013.2328","article-title":"Core binding factor acute myeloid leukaemia and c-KIT mutations","volume":"29","author":"Riera","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-2141.2004.04952.x","article-title":"WT1 gene expression: An excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients\u2014Results from a single-centre study","volume":"125","author":"Olesen","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.leu.2404149","article-title":"Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations","volume":"20","author":"Gorello","year":"2006","journal-title":"Leukemia"},{"key":"ref_33","unstructured":"Verma, R., and Babu, A. (1989). Human Chromosomes: Manual of Basic Techniques, Pergamon Press."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3324\/haematol.2018.191809","article-title":"Impact of FLT3-ITD length on prognosis of acute myeloid leukemia","volume":"104","author":"Liu","year":"2019","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","article-title":"Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: Implications for poor prognosis in AML","volume":"111","author":"Sallmyr","year":"2007","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1200\/JCO.2009.25.1496","article-title":"Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: A Cancer and Leukemia Group B study","volume":"28","author":"Becker","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Estey","year":"2017","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"20745","DOI":"10.1038\/s41598-021-00050-x","article-title":"Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens","volume":"11","author":"Sargas","year":"2021","journal-title":"Sci Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Giudice, V., Gorrese, M., Vitolo, R., Bertolini, A., Marcucci, R., Serio, B., Guariglia, R., Ferrara, I., Pepe, R., and D\u2019Alto, F. (2021). WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040387"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1179\/102453311X12902908411913","article-title":"Wilms\u2019 tumor protein and FLT3-internal tandem duplication expression in patients with de novo acute myeloid leukemia","volume":"16","author":"Spassov","year":"2011","journal-title":"Hematology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1200\/JCO.2009.22.4865","article-title":"Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leuke 511 mia: A European Leukemia Net study","volume":"27","author":"Cilloni","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"649267","DOI":"10.3389\/fphar.2021.649267","article-title":"Chemoresponse of de novo Acute Myeloid Leukemia to \u201c7+3\u201d Induction can Be Predicted by c-Myc-facitated Cytogenetics","volume":"12","author":"Hsiao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1101\/gad.232710.113","article-title":"Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation","volume":"27","author":"Shi","year":"2013","journal-title":"Genes Dev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cell.2018.05.048","article-title":"CBF\u03b2-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia","volume":"174","author":"Pulikkan","year":"2018","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12032-020-01436-z","article-title":"Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development","volume":"37","author":"Krygier","year":"2020","journal-title":"Med. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.18632\/oncotarget.1337","article-title":"MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia","volume":"5","author":"Astolfi","year":"2014","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3286949","DOI":"10.1155\/2018\/3286949","article-title":"The Myc\/Max\/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease","volume":"2018","author":"Basit","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_49","first-page":"4538","article-title":"Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma","volume":"63","author":"Alaminos","year":"2003","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"312ra176","DOI":"10.1126\/scitranslmed.aab1803","article-title":"Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma","volume":"7","author":"Carter","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/22350","article-title":"The chromatin-specifictranscription elongation factor FACT comprises human SPT16 and SSRP1 proteins","volume":"577","author":"Orphanides","year":"1999","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1085703","article-title":"FACT facilitates transcription-dependent nucleosome alteration","volume":"301","author":"Belotserkovskaya","year":"2003","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2008.12.005","article-title":"Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma","volume":"15","author":"Otto","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/bloodadvances.2018020305","article-title":"Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia","volume":"2","author":"Sakaguchi","year":"2018","journal-title":"Blood Adv."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1873-149X\/30\/3\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:23:46Z","timestamp":1760127826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1873-149X\/30\/3\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["pathophysiology30030024"],"URL":"https:\/\/doi.org\/10.3390\/pathophysiology30030024","relation":{},"ISSN":["1873-149X"],"issn-type":[{"value":"1873-149X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}